902
Views
13
CrossRef citations to date
0
Altmetric
Review

Fournier Gangrene in the Emergency Department: Diagnostic Dilemmas, Treatments and Current Perspectives

, , ORCID Icon, , ORCID Icon &
Pages 353-364 | Published online: 09 Nov 2020

References

  • Short B. Fournier gangrene: an historical reappraisal. Intern Med J. 2018;48(9):1157–1160. doi:10.1111/imj.14031
  • Grzybowski A, Short A. History of Fournier gangrene. Arch Dermatol. 2009;145(2):182. doi:10.1001/archdermatol.2008.595
  • El-Qushayri AE, Khalaf KM, Dahy A, et al. Fournier’s gangrene mortality: a 17-year systematic review and meta-analysis. Int J Infect Dis. 2020;92:218–225. doi:10.1016/j.ijid.2019.12.030
  • Filippone LM. MD diagnosis: Fournier’s gangrene. Emerg Med News. 2005;27(5):36. doi:10.1097/00132981-200505000-00029
  • Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344–362. doi:10.1067/j.cpsurg.2014.06.001
  • Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
  • Radcliffe RS, Khan MA. Mortality associated with Fournier’s gangrene remains unchanged over 25 years. BJU Int. 2020;125(4):610–616. doi:10.1111/bju.14998
  • Bjurlin MA, O’Grady T, Kim DY, et al. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier’s gangrene. Urology. 2013;81(4):752–758. doi:10.1016/j.urology.2012.12.041
  • Sorensen MD, Krieger JN, Rivara FP, et al. Fournier’s Gangrene: population based epidemiology and outcomes. J Urol. 2009;181(5):2120–2126. doi:10.1016/j.juro.2009.01.034
  • Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020;26(1):8–17. doi:10.1016/j.cmi.2019.06.031
  • Sugihara T, Yasunaga H, Horiguchi H, et al. Impact of surgical intervention timing on the case fatality rate for Fournier’s gangrene: an analysis of 379 cases. BJU Int. 2012;110(11c):E1096–1100. doi:10.1111/j.1464-410X.2012.11291.x
  • Voelzke BB, Hagedorn JC. Presentation and diagnosis of Fournier gangrene. Urology. 2018;114:8–13. doi:10.1016/j.urology.2017.10.031
  • Sorensen MD, Krieger JN. Fournier’s gangrene: epidemiology and outcomes in the general US population. Urol Int. 2016;97(3):249–259. doi:10.1159/000445695
  • Mishra SP, Singh S, Gupta SK. Necrotizing soft tissue infections: surgeon’s prospective. Int J Inflam. 2013;2013:609628. doi:10.1155/2013/609628
  • Thwaini A, Khan A, Malik A, et al. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006;82(970):516–519. doi:10.1136/pgmj.2005.042069
  • Elem B, Ranjan P. Impact of immunodeficiency virus (HIV) on Fournier’s gangrene: observations in Zambia. Ann R Coll Surg Engl. 1995;77(4):283–286.
  • Moussa M, Abou Chakra M. Isolated penile Fournier’s gangrene: a case report and literature review. Int J Surg Case Rep. 2019;62:65–68. doi:10.1016/j.ijscr.2019.08.012
  • Mouraviev VB, Pautler SE, Hayman WP. Fournier’s gangrene following penile self-injection with cocaine. Scand J Urol Nephrol. 2002;36(4):317–318. doi:10.1080/003655902320248326
  • Bloomgarden Z, Einhorn D, Grunberger G, Handelsman Y. Fournier’s gangrene and sodium-glucose cotransporter 2 inhibitors: is there a causal association? J Diabetes. 2019;11(5):340–341. doi:10.1111/1753-0407.12897
  • Yang JY, Wang T, Pate V, Buse JB, Stürmer T. Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene. BMJ Open Diabetes Res Care. 2020;8(1):e000985. doi:10.1136/bmjdrc-2019-000985
  • Dass AS, Immaculate G, Bhattacharyya A. Fournier’s gangrene and sodium-glucose co-transporter 2(SGLT2) inhibitors: our experience. Indian J Endocrinol Metab. 2019;23(1):165–166. doi:10.4103/ijem.IJEM_614_18
  • Aridogan IA, Izol V, Abat D, Karsli O, Bayazit Y, Satar N. Epidemiological characteristics of Fournier’s gangrene: a report of 71 patients. Urol Int. 2012;89(4):457–461. doi:10.1159/000342407
  • Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C. Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int. 2012;89(2):173–179. doi:10.1159/000339161
  • Chennamsetty A, Khourdaji I, Burks F, Killinger KA. Contemporary diagnosis and management of Fournier’s gangrene. Ther Adv Urol. 2015;7(4):203–215. doi:10.1177/1756287215584740
  • Fukui K, Fujioka M, Ishiyama S. Sacral pressure ulcer-induced Fournier’s gangrene extending to the retroperitoneum: a case report. Wounds. 2018;30(1):E5–E8.
  • Nigam V, Halim TA, Chhabra HS. Fournier’s gangrene in a female with spinal cord injury: a case report. Spinal Cord. 2010;48(3):268–269. doi:10.1038/sc.2009.127
  • Perkins TA, Bieniek JM, Sumfest JM. Solitary Candida albicans infection causing Fournier gangrene and review of fungal etiologies. Rev Urol. 2014;16(2):95–98.
  • Yüksel ÖH, Ürkmez A, Akan S, Verit A. A case of Fournier’s gangrene after inguinal hernia repair. Revista Internacional de Andrología. 2016;14(3):104–106. doi:10.1016/j.androl.2016.04.003
  • Chen Y, Wang X, Lin G, Xiao R. Successful treatment following early recognition of a case of Fournier’s scrotal gangrene after a perianal abscess debridement: a case report. J Med Case Rep. 2018;12(1):193.
  • Mostaghim A, Dhanani M, Ingalls RR. Fournier’s gangrene as an initial manifestation of acute promyelocytic leukemia: a case report and review of the literature. SAGE Open Med Case Rep. 2019;7:2050313X19834425. doi:10.1177/2050313X19834425
  • Katsanos KH, Ignatiadou E, Sarandi M, et al. Fournier’s gangrene complicating ulcerative pancolitis. J Crohns Colitis. 2010;4(2):203–206. doi:10.1016/j.crohns.2009.11.006
  • Dinc T, Kayilioglu SI, Sozen I, Yildiz BD, Coskun F. Fournier’s gangrene as a postoperative complication of inguinal hernia repair. Case Rep Surg. 2014;2014:408217.
  • Tang L-M, Su Y-J, Lai Y-C. The evaluation of microbiology and prognosis of Fournier’s gangrene in past five years. Springerplus. 2015;4(1):14. doi:10.1186/s40064-014-0783-8
  • Demir CY, Yuzkat N, Ozsular Y, Kocak OF, Soyalp C, Demirkiran H. Fournier gangrene: association of mortality with the complete blood count parameters. Plast Reconstr Surg. 2018;142(1):68e–75e. doi:10.1097/PRS.0000000000004516
  • Magdaleno-Tapial J, Valenzuela-Oñate C, Martínez-Doménech A, Sánchez-Carazo JL, Pérez-Ferriols A. Image gallery: Fournier gangrene in a patient with severe hidradenitis suppurativa. Br J Dermatol. 2019;181(3):e59. doi:10.1111/bjd.18052
  • Saijo S, Kuramoto Y, Yoshinari M, Tagami H. Extremely extended Fournier’s gangrene. Dermatologica. 1990;181(3):228–232. doi:10.1159/000247930
  • Cocanour CS, Chang P, Huston JM, et al. Management and novel adjuncts of necrotizing soft tissue infections. Surg Infect (Larchmt). 2017;18(3):250–272. doi:10.1089/sur.2016.200
  • Bonne SL, Kadri SS. Evaluation and management of necrotizing soft tissue infections. Infect Dis Clin North Am. 2017;31(3):497–511. doi:10.1016/j.idc.2017.05.011
  • Safioleas M, Stamatakos M, Mouzopoulos G, Diab A, Kontzoglou K, Papachristodoulou A. Fournier’s gangrene: exists and it is still lethal. Int Urol Nephrol. 2006;38(3–4):653–657. doi:10.1007/s11255-005-2946-6
  • Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg. 2000;87(6):718–728. doi:10.1046/j.1365-2168.2000.01497.x
  • Lin WT, Chao CM, Lin HL, Hung MC, Lai CC. Emergence of antibiotic-resistant bacteria in patients with Fournier gangrene. Surg Infect (Larchmt). 2015;16(2):165–168. doi:10.1089/sur.2013.118
  • Anantha RV, Kasper KJ, Patterson KG, Zeppa JJ, Delport J, McCormick JK. Fournier’s gangrene of the penis caused by Streptococcus dysgalactiae subspecies equisimilis: case report and incidence study in a tertiary-care hospital. BMC Infect Dis. 2013;13:381. doi:10.1186/1471-2334-13-381
  • Schmitz M, Roux X, Huttner B, Pugin J. Streptococcal toxic shock syndrome in the intensive care unit. Ann Intensive Care. 2018;8(1):88. doi:10.1186/s13613-018-0438-y
  • Grinev MV, Soroka IV, Grinev KM. [Fournier’s gangrene–a model of necrotizing fasciitis (clinical and pathogenetic aspects)]. Urologiia. 2007;(6):69–73. Russian.
  • Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36. doi:10.3389/fsurg.2014.00036
  • Jaworski R, Irga-Jaworska N, Naumiuk Ł, Chojnicki M, Haponiuk I. Fournier gangrene caused by Candida albicans in an infant after cardiac surgery. Mycopathologia. 2017;182(3–4):409–412. doi:10.1007/s11046-016-0086-4
  • Crowell W, Roberts R, Tarry S. Fungal Fourniers gangrene in an immunocompromised patient. Urol Case Rep. 2015;4:1–3.
  • Durand CM, Alonso CD, Subhawong AP, et al. Rapidly progressive cutaneous Rhizopus microsporus infection presenting as Fournier’s gangrene in a patient with acute myelogenous leukemia. Transpl Infect Dis. 2011;13(4):392–396. doi:10.1111/j.1399-3062.2011.00601.x
  • Tleyjeh IM, Routh J, Qutub MO, Lischer G, Liang KV, Baddour LM. Lactobacillus gasseri causing Fournier’s gangrene. Scand J Infect Dis. 2004;36(6–7):501–503. doi:10.1080/00365540410015916
  • Jensen P, Zachariae C, Grønhøj Larsen F. Necrotizing soft tissue infection of the glans penis due to atypical Candida species complicated with Fournier’s gangrene. Acta Derm Venereol. 2010;90(4):431–432. doi:10.2340/00015555-0847
  • Crowell W, Roberts R, Tarry S. Fungal Fourniers gangrene in an immunocompromised patient. Urol Case Rep. 2016;4:1–3. doi:10.1016/j.eucr.2015.09.009
  • Johnin K, Nakatoh M, Kadowaki T, Kushima M, Koizumi S, Okada Y. Fournier’s gangrene caused by Candida species as the primary organism. Urology. 2000;56(1):153. doi:10.1016/S0090-4295(00)00527-6
  • Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101(1):e119–125. doi:10.1002/bjs.9371
  • Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454–1460. doi:10.2106/00004623-200308000-00005
  • Parry N. Fournier gangrene. Clin Case Rep. 2015;3(3):198–199. doi:10.1002/ccr3.186
  • Ferreira PC, Reis JC, Amarante JM, et al. Fournier’s gangrene: a review of 43 reconstructive cases. Plast Reconstr Surg. 2007;119(1):175–184. doi:10.1097/01.prs.0000244925.80290.57
  • Talwar A, Puri N, Singh M. Fournier’s Gangrene of the penis: a rare entity. J Cutan Aesthet Surg. 2010;3(1):41–44. doi:10.4103/0974-2077.63394
  • Ferretti M, Saji AA, Phillips J. Fournier’s gangrene: a review and outcome comparison from 2009 to 2016. Adv Wound Care (New Rochelle). 2017;6(9):289–295. doi:10.1089/wound.2017.0730
  • Montrief T, Long B, Koyfman A, Auerbach J. Fournier gangrene: a review for emergency clinicians. J Emerg Med. 2019;57(4):488–500. doi:10.1016/j.jemermed.2019.06.023
  • Castleberg E, Jenson N, Dinh VA. Diagnosis of necrotizing faciitis with bedside ultrasound: the STAFF exam. West J Emerg Med. 2014;15(1):111–113. doi:10.5811/westjem.2013.8.18303
  • Torremadé Barreda J, Millán Scheiding M, Suárez Fernández C, et al. Fournier gangrene. A retrospective study of 41 cases. Cirugía Española (English Edition). 2010;87(4):218–223. doi:10.1016/S2173-5077(10)70051-X
  • Rodríguez Alonso A, Pérez García MD, Núñez López A, et al. [Fournier’s gangrene: anatomo-clinical features in adults and children. Therapy update].Actas Urol Esp.2000;24(4):294–306.doi:10.1016/S0210-4806(00)72452-1.Spanish.
  • Fernando SM, Tran A, Cheng W, et al. Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis. Ann Surg. 2019;269(1):58–65. doi:10.1097/SLA.0000000000002774
  • Doluoğlu ÖG, Karagöz MA, Kılınç MF, et al. Overview of different scoring systems in Fournier’s gangrene and assessment of prognostic factors. Turk J Urol. 2016;42(3):190–196. doi:10.5152/tud.2016.14194
  • Girgin R, Cinar O, Bulut E, Akduman B, Mungan NA. The role of the Platelet Mass Index (PMI) as a new prognostic factor in Fournier’s gangrene. Afri J Urol. 2018;24(3):226–232. doi:10.1016/j.afju.2018.06.002
  • Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–1541. doi:10.1097/01.CCM.0000129486.35458.7D
  • Burner E, Henderson SO, Burke G, Nakashioya J, Hoffman JR. Inadequate sensitivity of laboratory risk indicator to rule out necrotizing fasciitis in the emergency department. West J Emerg Med. 2016;17(3):333–336. doi:10.5811/westjem.2016.2.29069
  • Swain RA, Hatcher JC, Azadian BS, Soni N, De Souza B. A five-year review of necrotising fasciitis in a tertiary referral unit. Ann R Coll Surg Engl. 2013;95(1):57–60. doi:10.1308/003588413X13511609956093
  • Hodgins N, Damkat-Thomas L, Shamsian N, Yew P, Lewis H, Khan K. Analysis of the increasing prevalence of necrotising fasciitis referrals to a regional plastic surgery unit: a retrospective case series. J Plast Reconstr Aesthet Surg. 2015;68(3):304–311. doi:10.1016/j.bjps.2014.11.003
  • Wilson MP, Schneir AB. A case of necrotizing fasciitis with a LRINEC score of zero: clinical suspicion should trump scoring systems. J Emerg Med. 2013;44(5):928–931. doi:10.1016/j.jemermed.2012.09.039
  • Hsiao CT, Chang CP, Huang TY, Chen YC, Fann WC, Spratley J. Prospective validation of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score for necrotizing fasciitis of the extremities. PLoS One. 2020;15(1):e0227748. doi:10.1371/journal.pone.0227748
  • Kabay S, Yucel M, Yaylak F, et al. The clinical features of Fournier’s gangrene and the predictivity of the Fournier’s gangrene severity index on the outcomes. Int Urol Nephrol. 2008;40(4):997–1004. doi:10.1007/s11255-008-9401-4
  • Bozkurt O, Sen V, Demir O, Esen A. Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier’s gangrene. Int Urol Nephrol. 2015;47(2):243–248. doi:10.1007/s11255-014-0897-5
  • Forget P, Khalifa C, Defour J-P, Latinne D, Van Pel M-C, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12. doi:10.1186/s13104-016-2335-5
  • Yim SU, Kim SW, Ahn JH, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratios are more effective than the Fournier’s gangrene severity index for predicting poor prognosis in Fournier’s gangrene. Surg Infect (Larchmt). 2016;17(2):217–223. doi:10.1089/sur.2015.126
  • Kahramanca S, Kaya O, Özgehan G, et al. Are neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as effective as Fournier’s gangrene severity index for predicting the number of debridements in Fournier's gangrene? Ulus Travma Acil Cerrahi Derg. 2014;20(2):107–112. doi:10.5505/tjtes.2014.62829
  • Selvi I, Aykac A, Baran O, Burlukkara S, Ozok U, Sunay MM. A different perspective for morbidity related to Fournier’s gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier’s gangrene? Int Urol Nephrol. 2019;51(8):1303–1311. doi:10.1007/s11255-019-02188-0
  • Yíldírím A, Anuk T, Çığşar G. Clinical value of the monocyte-to-lymphocyte ratio for determining number of debridements in treatment of Fournier’s gangrene. Turk J Colorect Dis. 2017;27:43.
  • Ash L, Hale J. CT findings of perforated rectal carcinoma presenting as Fournier’s gangrene in the emergency department. Emerg Radiol. 2005;11(5):295–297. doi:10.1007/s10140-005-0417-0
  • Anaya DA, Dellinger EP, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705–710. doi:10.1086/511638
  • Wysoki MG, Santora TA, Shah RM, Friedman AC. Necrotizing fasciitis: CT characteristics. Radiology. 1997;203(3):859–863. doi:10.1148/radiology.203.3.9169717
  • Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008;28(2):519–528. doi:10.1148/rg.282075048
  • Rajan DK, Scharer KA. Radiology of Fournier’s gangrene. AJR Am J Roentgenol. 1998;170(1):163–168. doi:10.2214/ajr.170.1.9423625
  • Piedra T, Ruíz E, González FJ, Arnaiz J, Lastra P, López-Rasines G. Fournier’s gangrene: a radiologic emergency. Abdom Imaging. 2006;31(4):500–502. doi:10.1007/s00261-006-9035-x
  • Yen ZS, Wang HP, Ma HM, Chen SC, Chen WJ. Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med. 2002;9(12):1448–1451. doi:10.1197/aemj.9.12.1448
  • Di Serafino M, Gullotto C, Gregorini C, Nocentini C. A clinical case of Fournier’s gangrene: imaging ultrasound. J Ultrasound. 2014;17(4):303–306. doi:10.1007/s40477-014-0106-5
  • Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10–52.
  • Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010;75(4):249–257. doi:10.1016/j.jhin.2010.01.028
  • Saifee NH, Evans HL, Magaret AS, et al. Outcomes in necrotizing soft tissue infections treated with therapeutic plasma exchange. Transfusion. 2017;57(6):1407–1413. doi:10.1111/trf.14067
  • Benjelloun El B, Souiki T, Yakla N, et al. Fournier’s gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg. 2013;8(1):13. doi:10.1186/1749-7922-8-13
  • Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829–839. doi:10.1056/NEJMoa1711584
  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
  • Bentzer P, Griesdale DE, Boyd J, MacLean K, Sirounis D, Ayas NT. Will this hemodynamically unstable patient respond to a bolus of intravenous fluids? JAMA. 2016;316(12):1298–1309. doi:10.1001/jama.2016.12310
  • Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med. 2016;42(12):1935–1947. doi:10.1007/s00134-015-4134-1
  • Rosa I, Guerreiro F. Hyperbaric oxygen therapy for the treatment of Fournier’s gangrene: a review of 34 cases. Acta Med Port. 2015;28(5):619–623. doi:10.20344/amp.6300
  • Mindrup SR, Kealey GP, Fallon B. Hyperbaric oxygen for the treatment of Fournier’s gangrene. J Urol. 2005;173(6):1975–1977. doi:10.1097/01.ju.0000158129.56571.05
  • Norrby-Teglund A, Muller MP, McGeer A, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2005;37(3):166–172. doi:10.1080/00365540410020866
  • Abdrabou A. Fournier gangrene. Radiopedia. Available from: https://radiopaedia.org/cases/fournier-gangrene-5?lang=us. Accessed October 01, 2020.
  • O’Donnell C. Fournier gangrene - spontaneous perforation of rectal cancer. Radiopedia. Available from: https://radiopaedia.org/cases/fournier-gangrene-spontaneous-perforation-of-rectal-cancer?lang=us. Accessed October 01, 2020.
  • Jha P. Fournier gangrene. Radiopedia. Available from: https://radiopaedia.org/cases/fournier-gangrene-1?lang=us. Accessed October 01, 2020.